iRhythm Technologies Inc
IRTC179.430USD
-9.820-5.19%
Handelsschluss 01/09, 16:00（ET）Kurse um 15 Minuten verzögert
5.78BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über iRhythm Technologies Inc Unternehmen
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
iRhythm Technologies Inc Informationen
BörsenkürzelIRTC
Name des UnternehmensiRhythm Technologies Inc
IPO-datumOct 20, 2016
CEOBlackford (Quentin S)
Anzahl der mitarbeiter2000
WertpapierartOrdinary Share
GeschäftsjahresendeOct 20
Addresse699 8th Street
StadtSAN FRANCISCO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94103
Telefon14156325700
Websitehttps://www.irhythmtech.com/
BörsenkürzelIRTC
IPO-datumOct 20, 2016
CEOBlackford (Quentin S)
Führungskräfte von iRhythm Technologies Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.30K
-14059.00%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
33.85K
+73.00%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
18.46K
--
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
15.84K
-616.00%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
12.81K
+250.00%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+1358.00%
Mr. Bruce G. Bodaken
Mr. Bruce G. Bodaken
Independent Director
Independent Director
10.80K
+1358.00%
Karen Ling ,
Karen Ling ,
Independent Director
Independent Director
7.73K
+1358.00%
Mr. Daniel G. (Dan) Wilson
Mr. Daniel G. (Dan) Wilson
Chief Financial Officer
Chief Financial Officer
3.96K
-8000.00%
Dr. Cathleen Noel Bairey Merz, M.D.
Dr. Cathleen Noel Bairey Merz, M.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Quentin S. Blackford
Mr. Quentin S. Blackford
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
63.30K
-14059.00%
Ms. Sumi Shrishrimal
Ms. Sumi Shrishrimal
Executive Vice President, Chief Risk Officer
Executive Vice President, Chief Risk Officer
33.85K
+73.00%
Mr. Abhijit Y. (Abhi) Talwalkar
Mr. Abhijit Y. (Abhi) Talwalkar
Independent Chairman of the Board
Independent Chairman of the Board
18.46K
--
Mr. Mervin Smith
Mr. Mervin Smith
Executive Vice President - Business Operations
Executive Vice President - Business Operations
15.84K
-616.00%
Dr. Minang (Mintu) Turakhia, M.D.
Dr. Minang (Mintu) Turakhia, M.D.
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
Executive Vice President - Product Innovation Officer, Chief Scientific Officer, Chief Medical Officer
12.81K
+250.00%
Dr. Ralph Snyderman, M.D.
Dr. Ralph Snyderman, M.D.
Independent Director
Independent Director
11.45K
+1358.00%
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Commercial Payors
99.01M
51.33%
Contracted third-party payors
99.01M
51.33%
Centers for Medicare & Medicaid
47.56M
24.66%
Healthcare Institutions
32.79M
17.00%
Non-contracted third-party payors
13.52M
7.01%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Commercial Payors
99.01M
51.33%
Contracted third-party payors
99.01M
51.33%
Centers for Medicare & Medicaid
47.56M
24.66%
Healthcare Institutions
32.79M
17.00%
Non-contracted third-party payors
13.52M
7.01%
Aktionärsstatistik
Aktualisiert: Sun, Nov 30
Aktualisiert: Sun, Nov 30
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
10.03%
Artisan Partners Limited Partnership
7.97%
BlackRock Institutional Trust Company, N.A.
7.35%
Sands Capital Management, LLC
6.94%
Capital Research Global Investors
3.67%
Andere
64.04%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
10.03%
Artisan Partners Limited Partnership
7.97%
BlackRock Institutional Trust Company, N.A.
7.35%
Sands Capital Management, LLC
6.94%
Capital Research Global Investors
3.67%
Andere
64.04%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
63.25%
Investment Advisor/Hedge Fund
28.42%
Hedge Fund
10.19%
Research Firm
5.20%
Family Office
1.35%
Pension Fund
0.97%
Individual Investor
0.86%
Sovereign Wealth Fund
0.71%
Bank and Trust
0.54%
Institutionelle Beteiligung
Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
633
35.16M
109.12%
-4.05M
2025Q3
609
36.08M
112.00%
-5.27M
2025Q2
586
36.46M
113.50%
-2.59M
2025Q1
586
36.68M
114.94%
-2.13M
2024Q4
571
35.12M
111.82%
-4.41M
2024Q3
584
35.86M
114.62%
-4.91M
2024Q2
581
36.60M
117.28%
-2.20M
2024Q1
578
35.68M
114.75%
-1.24M
2023Q4
542
34.05M
110.03%
-1.99M
2023Q3
543
34.13M
111.64%
-2.86M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
3.23M
10.03%
+4.15K
+0.13%
Sep 30, 2025
Artisan Partners Limited Partnership
2.57M
7.97%
-173.33K
-6.32%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.37M
7.35%
+37.79K
+1.62%
Sep 30, 2025
Sands Capital Management, LLC
2.24M
6.94%
-679.42K
-23.30%
Sep 30, 2025
Capital Research Global Investors
1.18M
3.67%
-323.13K
-21.44%
Sep 30, 2025
State Street Investment Management (US)
847.88K
2.63%
-20.65K
-2.38%
Sep 30, 2025
Geode Capital Management, L.L.C.
790.10K
2.45%
+22.77K
+2.97%
Sep 30, 2025
William Blair & Company, L.L.C. (Research)
740.72K
2.3%
+1.39K
+0.19%
Sep 30, 2025
Eventide Asset Management, LLC
691.51K
2.15%
-61.00
-0.01%
Sep 30, 2025
Fuller & Thaler Asset Management Inc.
595.25K
1.85%
+8.77K
+1.50%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Global X HealthTech ETF
4.17%
First Trust Nasdaq Lux Digi Health Solutions ETF
2.08%
State Street SPDR S&P Health Care Equipment ETF
1.84%
Invesco Dorsey Wright Healthcare Momentum ETF
1.73%
Langar Global HealthTech ETF
1.72%
ROBO Global Healthcare Technology & Innovation ETF
1.66%
First Trust Multi-Manager Small Cap Opportunities ETF
1.55%
Inspire Fidelis Multi Factor ETF
1.09%
Harbor Health Care ETF
0.91%
Goldman Sachs Future Health Care Equity ETF
0.86%
Mehr Anzeigen
Global X HealthTech ETF
Anteil4.17%
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil2.08%
State Street SPDR S&P Health Care Equipment ETF
Anteil1.84%
Invesco Dorsey Wright Healthcare Momentum ETF
Anteil1.73%
Langar Global HealthTech ETF
Anteil1.72%
ROBO Global Healthcare Technology & Innovation ETF
Anteil1.66%
First Trust Multi-Manager Small Cap Opportunities ETF
Anteil1.55%
Inspire Fidelis Multi Factor ETF
Anteil1.09%
Harbor Health Care ETF
Anteil0.91%
Goldman Sachs Future Health Care Equity ETF
Anteil0.86%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von iRhythm Technologies Inc?
Die fünf größten Anteilseigner von iRhythm Technologies Inc sind:
The Vanguard Group, Inc. hält 3.23M Aktien, was 10.03% der Gesamtaktien entspricht.
Artisan Partners Limited Partnership hält 2.57M Aktien, was 7.97% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 2.37M Aktien, was 7.35% der Gesamtaktien entspricht.
Sands Capital Management, LLC hält 2.24M Aktien, was 6.94% der Gesamtaktien entspricht.
Capital Research Global Investors hält 1.18M Aktien, was 3.67% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 3.23M Aktien, was 10.03% der Gesamtaktien entspricht.
Artisan Partners Limited Partnership hält 2.57M Aktien, was 7.97% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 2.37M Aktien, was 7.35% der Gesamtaktien entspricht.
Sands Capital Management, LLC hält 2.24M Aktien, was 6.94% der Gesamtaktien entspricht.
Capital Research Global Investors hält 1.18M Aktien, was 3.67% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von iRhythm Technologies Inc?
Die drei wichtigsten Anteilseigner-Typen von iRhythm Technologies Inc sind:
The Vanguard Group, Inc.
Artisan Partners Limited Partnership
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Artisan Partners Limited Partnership
BlackRock Institutional Trust Company, N.A.
Wie viele Institutionen halten Anteile an iRhythm Technologies Inc (IRTC)?
Mit Stand vom 2025Q4 halten 633 Institutionen Anteile an iRhythm Technologies Inc, mit einem Gesamtmarktwert von etwa 35.16M, was 109.12% der Gesamtanteile entspricht. Im Vergleich zum 2025Q3 ist der institutionelle Aktienbesitz um -2.88% gestiegen.
Was ist die größte Einnahmequelle von iRhythm Technologies Inc?
Am FY2025Q3 erzielte das Geschäft mit Commercial Payors für iRhythm Technologies Inc den höchsten Umsatz in Höhe von 99.01M, was 51.33% des Gesamtumsatzes entspricht.
